25 Year Study Proves Effective Treatment
January 22, 2018
ESWL is a safe and effective method for treating urolithias, as evidenced in a 25-year study of 5,000+ patients. And, stone free rate was significantly better with a Dornier Delta lithotripter than other devices. The finding? Modern lithotripters combined with intelligent treatment strategies have made SWL a highly safe and effective method for treating urolithiasis in properly selected patients.
Click here to read about the study by J. Jagtap etal.
About Dornier MedTech – Dornier MedTech, a wholly-owned subsidiary of Accuron Medical Technology group (www.accuron.com), is a medical device company focused on providing leading technology and improving life by delivering scientifically superior products and solutions to physicians and patients involved in urological care. As pioneers of the lithotripsy and a variety of surgical lasers, Dornier’s 40 years of innovation and service has made it one of the most trusted MedTech companies in the industry. Dornier MedTech is headquartered in Munich, Germany with offices and distributors all over the world. For more information, visit www.dornier.com.
About the Accuron Medical Technology Group – The Accuron Medical Technology Group is a privately owned by Temasek Holdings, through the business of Dornier MedTech GmbH, Veredus Laboratories and Advanced Materials Technologies Pte Ltd, provide therapeutic, diagnostic, and medical device manufacturing solutions to customers around the globe. Veredus Laboratories Pte Ltd, specializes in the development, manufacture, and marketing of innovative molecular diagnostic solutions in the clinical, specialty, and custom testing markets based on a proprietary Lab-on-Chip platform. Advanced Materials Technologies Pte Ltd serves the contract manufacturing needs of the medical technology sector through providing materials expertise and high precision engineering capabilities.